Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nefrologia|January 21, 2023
Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registryCamilo Montero, Rodolfo Torres, Carlos Benavidez, et al.
Biomaterials Science|September 11, 2024
Dual-pore protocells with multitasking capacities for simultaneous delivery of therapeutic enzymes and drugs in macrophage depletion therapyJorge Parra-Nieto, Alicia Arroyo-Nogales, Diana Marcos-Fernández, et al.
The Journal of Manual & Manipulative Therapy|February 5, 2026
Effects of a high-force hip lateral distraction mobilization in individuals with hip-related groin pain: a randomized controlled trialSilvia Lahuerta-Martín, Ignacio Hernando-Garijo, Román Pérez-Robles, et al.
Musculoskeletal Science & Practice|March 26, 2019
Comparison of high, medium and low mobilization forces for reducing pain and improving physical function in patients with hip osteoarthritis: Secondary analysis of a randomized controlled trialElena Estébanez-de-Miguel, Sandra Jimenez-Del-Barrio, María Fortún-Agud, et al.
ACS Applied Bio Materials|January 15, 2022
Glucose-Responsive Enzyme-Controlled Mesoporous Nanomachine with a Layer-by-Layer Supramolecular ArchitectureSandra Jimenez-Falcao, Beatriz de Luis, Alba García-Fernández, et al.
Journal of Materials Chemistry. B|August 1, 2019
Janus nanocarrier powered by bi-enzymatic cascade system for smart deliverySandra Jimenez-Falcao, Natalia Joga, Alba García-Fernández, et al.
Brain : a Journal of Neurology|September 18, 2015
Brain endothelial dysfunction in cerebral adrenoleukodystrophyPatricia L Musolino, Yi Gong, Juliet M T Snyder, et al.
Journal of Materials Chemistry. B|August 25, 2022
An enzyme-controlled mesoporous nanomachine for triple-responsive deliveryBeatriz Mayol, Victor Dato, Manuel Rodriguez, et al.
Journal of Child Neurology|September 15, 2020
Boricua Founder Variant in FRRS1L Causes Epileptic Encephalopathy With Hyperkinetic MovementsImane Abdelmoumen, Sandra Jimenez, Ignacio Valencia, et al.
Eclinicalmedicine|June 13, 2025
Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trialÁngeles García-Cazorla, Caroline Sevin, Juliana Ribeiro Constante, et al.
Pageof 3